NEW YORK–(BUSINESS WIRE)–Lemonade, Inc. (“Lemonade”) today announced that it has commenced the initial public offering of its common stock. Lemonade is offering 11,000,000 shares of its common stock. The initial […]

IPO Edge, in partnership with Desert Hawk Gold Corporation, owner of a fully-permitted, operating mine in Utah, and The Palm Beach Hedge Fund Association, a Florida trade association for financial professionals, hosted […]

LAS VEGAS–(BUSINESS WIRE)–Cannae Holdings, Inc. (NYSE:CNNE) (“Cannae”) today announced that Dun & Bradstreet Holdings, Inc. (“Dun & Bradstreet”), a Cannae portfolio company, launched its initial public offering of 65,750,000 shares […]

IPO Edge, in partnership with Desert Hawk Gold Corporation, owner of a fully-permitted, operating mine in Utah, and The Palm Beach Hedge Fund Association, a Florida trade association for financial professionals, […]

Joe Marinucci, CEO of Digital Media Solutions Holdings, LLC, which is Merging with Leo Holdings Corp. to Trade on NYSE By John Jannarone These days, digital impressions or even clicks […]

CAMBRIDGE, Mass. & MONTREAL–(BUSINESS WIRE)–Repare Therapeutics Inc. (Nasdaq: RPTX), a leading precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics, today […]

WATERTOWN, Mass.–(BUSINESS WIRE)–Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced the closing of its initial public offering of 15,964,704 […]

NEW YORK–(BUSINESS WIRE)–Trebia Acquisition Corp. (the “Company”) (NYSE: TREB.U) today announced the closing of its initial public offering of 51,750,000 units, which includes 6,750,000 units issued upon the exercise of […]

CHICAGO–(BUSINESS WIRE)–GoHealth, Inc. (“GoHealth”) today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to the proposed initial public […]

CAMBRIDGE, Mass. & MONTRÉAL–(BUSINESS WIRE)–Repare Therapeutics Inc. (Nasdaq: RPTX), a leading precision oncology company enabled by our proprietary synthetic lethality approach to the discovery and development of novel therapeutics, today […]